Three Different Doses of Neostigmine on the Reversal of Cisatracurium-induced Moderate Neuromuscular Blockade

NCT05037006 · clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
90
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Pontificia Universidade Catolica de Sao Paulo